Skip to main content

PharmacoEconomics

Ausgabe 12/2019

Inhalt (11 Artikel)

Acknowledgement to Referees

Acknowledgement to Referees

Editorial

Could or Should We Use MCDA in the French HTA Process?

Salah Ghabri, Jean-Michel Josselin, Benoît Le Maux

Open Access Systematic Review

Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design

Daniel M. Sugrue, Thomas Ward, Sukhvir Rai, Phil McEwan, Heleen G. M. van Haalen

Systematic Review

The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments

Fernando Antonanzas, Carmelo Juárez-Castelló, Reyes Lorente, Roberto Rodríguez-Ibeas

Original Research Article

Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort

Michael Laxy, Verena Maria Schöning, Christoph Kurz, Rolf Holle, Annette Peters, Christa Meisinger, Wolfgang Rathmann, Kristin Mühlenbruch, Katharina Kähm

Original Research Article

Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II—An Updated Analysis of SEER-Medicare Data

Ya-Chen Tina Shih, Ying Xu, Chun-Ru Chien, Bumyang Kim, Yu Shen, Liang Li, Daniel M. Geynisman

Original Research Article

Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn’s Disease

Heather Catt, Keith Bodger, Jamie J. Kirkham, Dyfrig A. Hughes

Original Research Article

A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost‑Effectiveness Analysis

Sandjar Djalalov, Jaclyn Beca, Emmanuel M. Ewara, Jeffrey S. Hoch

Original Research Article

Assessment-Schedule Matching in Unanchored Indirect Treatment Comparisons of Progression-Free Survival in Cancer Studies

Venediktos Kapetanakis, Thibaud Prawitz, Michael Schlichting, K. Jack Ishak, Hemant Phatak, Mairead Kearney, John W. Stevens, Agnes Benedict, Murtuza Bharmal